Navigation Links
Myriant and Azelis Sign European Distribution Agreement for Bio-Succinic Acid
Date:9/2/2014

Quincy, MA (PRWEB) September 02, 2014

Myriant Corporation, a global renewable chemicals company, announced today the signage of a distribution agreement with Azelis Group, a specialty chemicals distribution leader. Azelis is now distributing Myriant’s bio-succinic acid in the Nordics, Benelux, France, Iberia, Italy, the United Kingdom and Ireland, targeting customers in the industrial and base chemicals markets.

“As a global chemical distribution powerhouse, Azelis offers a far-reaching chemical portfolio with extensive distribution networks providing Myriant the necessary support and connections with chemical companies seeking to integrate “green” chemicals into a wide range of applications,” said David LeBlanc, Head of Global Sales and Marketing for Myriant.

Myriant currently supplies bio-succinic acid from its flagship facility located in Lake Providence, Louisiana, with nameplate capacity of 30 million pounds per year. Globally, the annual worldwide market for succinic acid is estimated at approximately $7.5 billion in existing and new applications, in the field of polymers, urethanes, plasticizers and coatings. Myriant's high purity bio-succinic acid is made from renewable feedstocks and is chemically equivalent to petroleum-based succinic acid while providing a lower environmental footprint. Myriant’s bio-succinic acid reduces harmful green house gas emissions by 94% compared to petroleum-derived succinic acid and by 96% compared to petroleum-derived adipic acid, a chemical that succinic acid can replace.

Azelis, a global leader in the sales, marketing and distribution of specialty chemicals, has a strong commitment to sustainability and achieving reduction of green house gases is one of its top corporate priorities. “We are delighted to partner with Myriant for this leading and exciting new generation product,” said Laurent Nataf, COO Azelis. “Myriant further strengthens Azelis’ offering in the renewable resources based chemistry for production of more sustainable polymers. We are currently experiencing a growing demand for sustainable products and we believe Myriant will be a part of sourcing these new renewable chemicals.”

About Myriant Corporation
Myriant is a global leader innovating and commercializing bio-based chemical intermediates with a focus on bio-succinic acid, bio-butanediol and bio-acrylic acid. Myriant is currently commercializing bio-succinic acid from its flagship plant in Lake Providence, LA.

About Azelis
Azelis is the leading global specialty chemicals distributor providing a diverse range of innovative products and services. We serve 20,000 customers in the coatings, chemicals, rubber & plastic additives, food & health, animal nutrition, pharma and personal care industries.

Through sourcing and distribution channels in every major market around the world, Azelis with its corporate service centre in Antwerp, Belgium, offers chemical producers market penetration, in-depth local knowledge, value-added services and tailored multi-territory solutions. Azelis, backed by private equity investor 3i Investments PLC, has a turnover of €1 billion and employs around 1,100 knowledgeable people located in more than 37 facilities in 34 countries across Europe, China, Australia, Canada, India, Japan, Malaysia and Singapore.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12132746.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
2. Myriant to Participate in U.S. DOE Biomass 2013 Conference
3. Myriant Selected as a 2013 Red Herring Top 100 Global Company
4. Myriant to Participate in BIO Pacific Rim Summit
5. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
6. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
7. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
8. European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan
9. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
10. Tackling the European market of nanoimprint lithography
11. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... cells — optogenetics — is key to exciting advances in the study and ... patterned light projected via free-space optics stimulates small, transparent organisms and excites neurons ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc announced ... client demand KbioBox developed a sophisticated “3 click” gene dditing off target analysis ... KBioBox’s new website, https://www.kbiobox.com/ and powered by the company’s proprietary ...
(Date:12/8/2016)... 8, 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... developing and commercializing products to treat rare diseases where ... it will be hosting an Investor Webcast Event Friday, ... origins of innate defense regulators (IDRs) as a new ... mucositis and the recently announced and published Phase 2 ...
(Date:12/8/2016)...   Biocept, Inc . (NASDAQ: ... actionable liquid biopsy tests to improve the management ... its Target Selector™ Circulating Tumor Cell platform demonstrated ... of actionable biomarkers in patients with metastatic breast ... Cannon Research Institute (SCRI), the research arm of ...
Breaking Biology Technology:
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
Breaking Biology News(10 mins):